Anti-nucleosome antibodies increase the risk of renal relapse in a prospective cohort of patients with clinically inactive systemic lupus erythematosus

An important goal in the management of systemic lupus erythematosus (SLE) is the prediction of relapses. This study assesses whether anti-nucleosome antibodies (anti-NCS) increase the risk of renal relapse in inactive SLE. A prospective cohort of 115 patients with inactive SLE (M-SLEDAI ≤ 2) were fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodriguez-Jimenez, Norma Alejandra, Perez-Guerrero, Edsaul Emilio, Gamez-Nava, Jorge Ivan, Sanchez-Mosco, Dalia Isabel, Saldaña-Cruz, Ana Miriam, Alcaraz-Lopez, Miriam Fabiola, Fajardo-Robledo, Nicte Selene, Muñoz-Valle, Jose Francisco, Bonilla-Lara, David, Diaz-Rizo, Valeria, Gonzalez-Lopez, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391650/
https://www.ncbi.nlm.nih.gov/pubmed/32728051
http://dx.doi.org/10.1038/s41598-020-69608-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391650/
https://www.ncbi.nlm.nih.gov/pubmed/32728051
http://dx.doi.org/10.1038/s41598-020-69608-5

Ejemplares similares